Skip to content
  • Spain
  • United Kingdom
  • Europe
  • United States
  • Japan
  • The Middle East
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
  • Russia
  • Chile
  • Argentina
  • Turkey
  • Colombia
  • 语言
  • +86 400-066-9501 联系我们
  • +86 400-066-9501 联系我们
ChinaChina
  • 我是备孕爸妈
  • 我是生殖医学专家
  • 最新动态
  • ERA合作医院
  • 微信极速客服
检测服务 > Oncodona

Oncodona

A complete test of genetic screening that analyzes 21 genes related to breast and ovarian cancer.

  • Overview
  • Features
  • How does it Work?
  • I’m a health specialist

Early identification of predisposition to inherited cancer.

Results in 30 days.

Harmful mutations can be transmitted with a 50% probability.

Overview

What is Oncodona test?

  • Oncodona is the most advanced genetic test for early identification of predisposition to inherited cancer.
  • This test analyzes 21 genes related to breast and ovarian cancer in order to locate mutations that increase the risk of developing these types of cancer.
  • Oncodona uses Next Generation Sequencing (NGS) to analyze genetic information present in a panel of 21 genes, including BRCA1 and BRCA2 genes, in order to locate harmful mutations.
Features
  • Indications
  • Benefits

Is Oncodona for you?

This test is recommended if:

  • You’ve been diagnosed with breast cancer and BRCA1 and BRCA2 negative genetic test. Oncodona can find a mutation in up to 4% of women.
  • A woman in your family has been diagnosed with breast and ovarian cancer. 
  • You just want to know if you have any risk of developing breast and ovarian cancer.

Why use Oncodona?

  • The performance of the test, if positive, can be used to adopt follow-up and personalized early detection measures of the patient and their relatives.
  • A negative result means that the patient does not have an increased risk. In other words, their risk of suffering one of the types of cancer analysed by the test is the baseline risk of the population.
How does it work?

BROCHURE

Download
email

Subscribe to
our newsletter

[gravityform id=1 title=false description=false ajax=true tabindex=49]

What now?

[gravityform id=4 title=false description=false ajax=true tabindex=49]

Other services you may be interested

CGT
特定基因携带者检测

遗传性疾病无法治愈，但可以预防。

PGT-M

Prevents the transmission of single gene disorders

More information

PGT-A

Chromosomally normal embryos selection

More information

Igenomix 媒體報導
Igenomix China Logo

使用指引

我们的服务

关于奕真生物

Work with us

Igenomix 在中国的所有检测服务，均由杭州奕真医学检验所有限公司（下文简称“奕真生物”）完成。奕真生物于 2015 年创立，为全中资的独立医学检验所，拥有由资深专家组成的本地基因分析、 解读、和咨询团队， 实验室已获得国家批准的实验室医疗机构执业许可资质，和美国 CAP 和 CLIA 认证（证书见下方）。2019 年 3 月，奕真生物与 Igenomix 宣布战略合作，引入 Igenomix 生殖遗传检测产品线，为中国市场提供辅助生殖基因检测服务。

China lab certification
+86-400-066-9501
supportchina@igenomix.cn
语言

[2020] © Igenomix

浙ICP备2021032808号-1

联系我们


    • reCAPTCHA demo: Simple page

  • 我是备孕爸妈
  • 我是生殖医学专家
  • 最新动态
  • ERA合作医院
  • 微信极速客服
  • 语言